ctrl K

Watchlist Price Alert

Calidi Biotherapeutics In... (CLDI)

AMEX: CLDI · Real-Time Price · USD

0.44

0.03 (6.02%)

At close: May 09, 2025, 10:48 AM

Calidi Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.59M	2.05M	472K	1.06M	420K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	230K	n/a	230M	n/a
Other Long-Term Assets	1.02M	143K	725K	-304.06K	616K
Receivables	n/a	1.36M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	249K	125K	100K	n/a	n/a
Total Current Assets	10.23M	4.3M	786K	1.48M	513K
Property-Plant & Equipment	2.93M	5.34M	1.09M	585K	723K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.96M	5.72M	1.81M	230.29M	1.34M
Total Assets	14.18M	10.02M	2.6M	231.77M	1.85M
Account Payables	2.07M	2.88M	2.27M	624K	973K
Deferred Revenue	n/a	n/a	n/a	-5.14M	1.69M
Short-Term Debt	3.18M	807K	5.42M	5M	4.94M
Other Current Liabilities	2.9M	n/a	29.83M	-8.86M	1.1M
Total Current Liabilities	9.5M	10.23M	42.99M	410.99K	8.89M
Long-Term Debt	600K	2.06M	n/a	n/a	6.37M
Other Long-Term Liabilities	2.12M	2.71M	n/a	16M	9M
Total Long-Term Liabilities	2.72M	8.02M	447K	16.04M	15.44M
Total Liabilities	12.21M	18.25M	43.44M	16.45M	24.33M
Total Debt	7.04M	7.24M	5.99M	5.18M	11.72M
Common Stock	2K	4K	2K	230.01M	2K
Retained Earnings	-121.72M	-99.57M	-70.36M	-14.69M	-34.44M
Comprehensive Income	-28K	-47K	-14K	-1K	6K
Shareholders Equity	1.53M	-8.23M	-40.84M	215.32M	-22.48M
Total Investments	n/a	230K	n/a	230M	n/a